Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Jovanovic, Marija (57194767566)"

Filter results by typing the first few letters
Now showing 1 - 12 of 12
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Computational modeling of atherosclerotic plaque progression in carotid lesions with moderate degree of stenosis
    (2021)
    Mantzaris, Michalis D. (24478053800)
    ;
    Siogkas, Panagiotis K. (36976596100)
    ;
    Tsakanikas, Vassilis D. (36718299600)
    ;
    Potsika, Vassiliki T. (55826618900)
    ;
    Pleouras, Dimitrios S. (57213604972)
    ;
    Sakellarios, Antonis I. (36476633700)
    ;
    Karagiannis, Georgios (57509364400)
    ;
    Galyfos, George (55658700300)
    ;
    Sigala, Fragiska (55393308900)
    ;
    Liasis, Nikolaos (10440375500)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Koncar, Igor B. (19337386500)
    ;
    Kallmayer, Michael (41861588900)
    ;
    Fotiadis, Dimitrios I. (55938920100)
    Carotid atherosclerotic plaque growth leads to the progressive luminal stenosis of the vessel, which may erode or rupture causing thromboembolism and cerebral infarction, manifested as stroke. Carotid atherosclerosis is considered the major cause of ischemic stroke in Europe and thus new imaging-based computational tools that can improve risk stratification and management of carotid artery disease patients are needed. In this work, we present a new computational approach for modeling atherosclerotic plaque progression in real patient-carotid lesions, with moderate to severe degree of stenosis (>50%). The model incorporates for the first time, the baseline 3D geometry of the plaque tissue components (e.g. Lipid Core) identified by MR imaging, in which the major biological processes of atherosclerosis are simulated in time. The simulated plaque tissue production results in the inward remodeling of the vessel wall promoting luminal stenosis which in turn predicts the region of the actual stenosis progression observed at the follow-up visit. The model aims to support clinical decision making, by identifying regions prone to plaque formation, predict carotid stenosis and plaque burden progression, and provide advice on the optimal time for patient follow-up screening. © 2021 IEEE.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Computational modeling of atherosclerotic plaque progression in carotid lesions with moderate degree of stenosis
    (2021)
    Mantzaris, Michalis D. (24478053800)
    ;
    Siogkas, Panagiotis K. (36976596100)
    ;
    Tsakanikas, Vassilis D. (36718299600)
    ;
    Potsika, Vassiliki T. (55826618900)
    ;
    Pleouras, Dimitrios S. (57213604972)
    ;
    Sakellarios, Antonis I. (36476633700)
    ;
    Karagiannis, Georgios (57509364400)
    ;
    Galyfos, George (55658700300)
    ;
    Sigala, Fragiska (55393308900)
    ;
    Liasis, Nikolaos (10440375500)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Koncar, Igor B. (19337386500)
    ;
    Kallmayer, Michael (41861588900)
    ;
    Fotiadis, Dimitrios I. (55938920100)
    Carotid atherosclerotic plaque growth leads to the progressive luminal stenosis of the vessel, which may erode or rupture causing thromboembolism and cerebral infarction, manifested as stroke. Carotid atherosclerosis is considered the major cause of ischemic stroke in Europe and thus new imaging-based computational tools that can improve risk stratification and management of carotid artery disease patients are needed. In this work, we present a new computational approach for modeling atherosclerotic plaque progression in real patient-carotid lesions, with moderate to severe degree of stenosis (>50%). The model incorporates for the first time, the baseline 3D geometry of the plaque tissue components (e.g. Lipid Core) identified by MR imaging, in which the major biological processes of atherosclerosis are simulated in time. The simulated plaque tissue production results in the inward remodeling of the vessel wall promoting luminal stenosis which in turn predicts the region of the actual stenosis progression observed at the follow-up visit. The model aims to support clinical decision making, by identifying regions prone to plaque formation, predict carotid stenosis and plaque burden progression, and provide advice on the optimal time for patient follow-up screening. © 2021 IEEE.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Differentiation between progression and pseudoprogression by arterial spin labeling MRI in patients with glioblastoma multiforme
    (2017)
    Jovanovic, Marija (57194767566)
    ;
    Radenkovic, Sandra (36615697100)
    ;
    Stosic-Opincal, Tatjana (55886486600)
    ;
    Lavrnic, Slobodan (23473613300)
    ;
    Gavrilovic, Svet-lana (8368352800)
    ;
    Lazovic-Popovic, Biljana (36647776000)
    ;
    Soldatovic, Ivan (35389846900)
    ;
    Maksimovic, Ruzica (55921156500)
    Purpose: To compare arterial spin labeling (ASL) perfusion technique with the clinically established dynamic susceptibility contrast-enhanced (DSC) perfusion weighted-imaging (PWI), and to determine its value in routine MRI evaluation of disease progression in patients with glioblastoma multiforme (GBM). Methods: A prospective intraindividual study was performed in 31 patients with histologically proven GBM who had clinical and/or radiological deterioration after treatment, including surgery, radiotherapy and therapy with temozolomide. Conventional brain protocol with ASL and DSC techniques was performed on 3T MRI unit. Cerebral blood flow (CBF) and cerebral blood volume (CBV) maps were analyzed by means of regions of interest (ROI). Each ROI average value was normalized to the contralateral normal brain parenchyma ROI value. Neuroradiologists analyzed CBF and CBV maps separately, and classified patients into progression or pseudoprogression group. Radiological diagnosis was confirmed by clinical-radiological follow-up for at least three months after patient deterioration. Results: High linear correlation existed between DSC-PWI and ASL in the tumor ROI (r=0.733; p<0.001). 92% of ASL CBF maps were informative. ASL detected all lesions as well as DSC MRI. Both techniques provided perfusion values closely correlated. Conclusion: ASL allows distinction between GBM progression and pseudoprogression, and it can be used as reliable alternative to DSC-PWI. © 2017 Zerbinis Publications. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Differentiation between progression and pseudoprogression by arterial spin labeling MRI in patients with glioblastoma multiforme
    (2017)
    Jovanovic, Marija (57194767566)
    ;
    Radenkovic, Sandra (36615697100)
    ;
    Stosic-Opincal, Tatjana (55886486600)
    ;
    Lavrnic, Slobodan (23473613300)
    ;
    Gavrilovic, Svet-lana (8368352800)
    ;
    Lazovic-Popovic, Biljana (36647776000)
    ;
    Soldatovic, Ivan (35389846900)
    ;
    Maksimovic, Ruzica (55921156500)
    Purpose: To compare arterial spin labeling (ASL) perfusion technique with the clinically established dynamic susceptibility contrast-enhanced (DSC) perfusion weighted-imaging (PWI), and to determine its value in routine MRI evaluation of disease progression in patients with glioblastoma multiforme (GBM). Methods: A prospective intraindividual study was performed in 31 patients with histologically proven GBM who had clinical and/or radiological deterioration after treatment, including surgery, radiotherapy and therapy with temozolomide. Conventional brain protocol with ASL and DSC techniques was performed on 3T MRI unit. Cerebral blood flow (CBF) and cerebral blood volume (CBV) maps were analyzed by means of regions of interest (ROI). Each ROI average value was normalized to the contralateral normal brain parenchyma ROI value. Neuroradiologists analyzed CBF and CBV maps separately, and classified patients into progression or pseudoprogression group. Radiological diagnosis was confirmed by clinical-radiological follow-up for at least three months after patient deterioration. Results: High linear correlation existed between DSC-PWI and ASL in the tumor ROI (r=0.733; p<0.001). 92% of ASL CBF maps were informative. ASL detected all lesions as well as DSC MRI. Both techniques provided perfusion values closely correlated. Conclusion: ASL allows distinction between GBM progression and pseudoprogression, and it can be used as reliable alternative to DSC-PWI. © 2017 Zerbinis Publications. All rights reserved.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Progressive postoperative atrophy of ipsilateral thalamus, putamen, and globus pallidus in patients with temporal lobe epilepsy: A volumetric analysis
    (2024)
    Pejovic, Aleksa (57188722535)
    ;
    Jokovic, Zorica (55615573000)
    ;
    Koepp, Matthias (7003606118)
    ;
    Dakovic, Marko (23491743200)
    ;
    Bascarevic, Vladimir (36485908900)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Vojvodic, Nikola (6701469523)
    ;
    Sokic, Dragoslav (35611592800)
    ;
    Ristic, Aleksandar J. (7003835405)
    Objective: Cortical atrophy close to medial temporal structures has been described consistently in patients with temporal lobe epilepsy (TLE). Successful TLE surgery may have a neuroprotective effect preventing further atrophy of temporal and extratemporal cortex. However, the effects of epilepsy surgery on subcortical structures demand additional enlightenment. This work aimed to determine how epilepsy surgery affects volumes of subcortical structures in medically refractory temporal lobe epilepsy patients. Methods: We compared MRI volumes of subcortical structures in 62 patients with TLE (36 left, 26 right) before and after anterior temporal lobectomy with 38 TLE patients (20 left, 18 right) who were considered to be good surgical candidates and had at least two brain MRIs. Results: There were no volume differences in subcortical structures on preoperative and initial MRIs of non-operated TLE patients. At baseline, the ipsilateral thalamus and putamen in TLE patients were marginally smaller than contralateral structures. Operated patients showed a significant postoperative volume reduction in ipsilateral thalamus, putamen, and globus pallidus. In contrast, there were no significant volumetric reductions in non-operated patients longitudinally. There were no volumetric changes associated with different surgical outcomes or different postoperative cognitive outcomes. Significance: Our study demonstrated postoperative volume loss of thalamus, putamen and globus pallidus ipsilaterally to the side of resection. Our findings suggest surgery-related changes, likely Wallerian degeneration within subcortical networks not related to seizure or cognitive outcome. Plain Language Summary: We studied 100 patients with epilepsy, comparing those who had surgery to those who did not. After surgery, the thalamus, putamen and globus pallidus on the same side as the surgery shrank significantly, but not in non-surgery patients. This suggests surgery-related changes in deeper brain structures, unrelated to seizure freedom or cognitive outcomes. This research sheds additional light on the response of the subcortical structure to epilepsy surgery, highlighting potential areas for further study. © 2024 The Author(s). Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Progressive postoperative atrophy of ipsilateral thalamus, putamen, and globus pallidus in patients with temporal lobe epilepsy: A volumetric analysis
    (2024)
    Pejovic, Aleksa (57188722535)
    ;
    Jokovic, Zorica (55615573000)
    ;
    Koepp, Matthias (7003606118)
    ;
    Dakovic, Marko (23491743200)
    ;
    Bascarevic, Vladimir (36485908900)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Vojvodic, Nikola (6701469523)
    ;
    Sokic, Dragoslav (35611592800)
    ;
    Ristic, Aleksandar J. (7003835405)
    Objective: Cortical atrophy close to medial temporal structures has been described consistently in patients with temporal lobe epilepsy (TLE). Successful TLE surgery may have a neuroprotective effect preventing further atrophy of temporal and extratemporal cortex. However, the effects of epilepsy surgery on subcortical structures demand additional enlightenment. This work aimed to determine how epilepsy surgery affects volumes of subcortical structures in medically refractory temporal lobe epilepsy patients. Methods: We compared MRI volumes of subcortical structures in 62 patients with TLE (36 left, 26 right) before and after anterior temporal lobectomy with 38 TLE patients (20 left, 18 right) who were considered to be good surgical candidates and had at least two brain MRIs. Results: There were no volume differences in subcortical structures on preoperative and initial MRIs of non-operated TLE patients. At baseline, the ipsilateral thalamus and putamen in TLE patients were marginally smaller than contralateral structures. Operated patients showed a significant postoperative volume reduction in ipsilateral thalamus, putamen, and globus pallidus. In contrast, there were no significant volumetric reductions in non-operated patients longitudinally. There were no volumetric changes associated with different surgical outcomes or different postoperative cognitive outcomes. Significance: Our study demonstrated postoperative volume loss of thalamus, putamen and globus pallidus ipsilaterally to the side of resection. Our findings suggest surgery-related changes, likely Wallerian degeneration within subcortical networks not related to seizure or cognitive outcome. Plain Language Summary: We studied 100 patients with epilepsy, comparing those who had surgery to those who did not. After surgery, the thalamus, putamen and globus pallidus on the same side as the surgery shrank significantly, but not in non-surgery patients. This suggests surgery-related changes in deeper brain structures, unrelated to seizure freedom or cognitive outcomes. This research sheds additional light on the response of the subcortical structure to epilepsy surgery, highlighting potential areas for further study. © 2024 The Author(s). Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Secondary vs. primary pituitary xanthogranulomas: which yellow is more mellow?
    (2024)
    Miljic, Dragana (6505968542)
    ;
    Pekic, Sandra (6602553641)
    ;
    Doknic, Mirjana (6603478362)
    ;
    Stojanovic, Marko (58191563300)
    ;
    Ilic, Sasa (57800086700)
    ;
    Djurovic, Marina Nikolic (6603668923)
    ;
    Jemuovic, Zvezdana (57195299822)
    ;
    Milojevic, Toplica (57184201100)
    ;
    Milicevic, Mihailo (57219130278)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Stojanoska, Milica Medic (23389630200)
    ;
    Carić, Bojana (57226110329)
    ;
    Radic, Nevena (57193631673)
    ;
    Medenica, Sanja (33568078600)
    ;
    Gacic, Emilija Manojlovic (57195247701)
    ;
    Petakov, Milan (7003976693)
    Pituitary xanthogranulomatomas (XG) are a rare pathological entity caused by accumulation of lipid laden macrophages and reactive granuloma formation usually triggered by cystic fluid leakage or hemorrhage. Our aim was to compare clinical characteristics and presenting features of patients with secondary etiology of XG and those with no identifiable founding lesion (primary-“pure” XG) in order to gain new insights into this rare pituitary pathology. In a retrospective review of 714 patients operated for sellar masses, at tertiary center, we identified 16 (2.24%) with histologically confirmed diagnosis of pituitary XG over the period of 7 years (2015–2021). Patients were further analyzed according to XG etiology: “pure”-XG (n = 8) with no identifiable founding lesion were compared to those with histological elements of pituitary tumor or cyst – secondary XG (n = 8). We identified 16 patients (11 male), mean age 44.8 ± 22.3 years, diagnosed with pituitary XG. Secondary forms were associated with Ratke’s cleft cyst (RCC, n = 2) and pituitary adenoma (PA, n = 6). The most common presenting features in both groups were hypopituitarism (75%), headache (68.5%) and visual disturbances (37.5%). Predominance of male sex was noted (males 68.75%, females 31.25%), especially in patients with primary forms. Patients with primary pituitary XG were all males (p = 0.0256) and more frequently affected by panhypopituitarism (87.5% vs. 25%, p = 0.0406) compared to patients with secondary causes. Hyperprolactinemia was noted in pituitary tumor group with secondary etiology only (p = 0.0769). Majority of lesions were solid on magnetic resonance imaging-MRI (81.25%). Distinct clinical phenotype was observed dependent on the etiology of XG. © The Japan Endocrine Society.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Secondary vs. primary pituitary xanthogranulomas: which yellow is more mellow?
    (2024)
    Miljic, Dragana (6505968542)
    ;
    Pekic, Sandra (6602553641)
    ;
    Doknic, Mirjana (6603478362)
    ;
    Stojanovic, Marko (58191563300)
    ;
    Ilic, Sasa (57800086700)
    ;
    Djurovic, Marina Nikolic (6603668923)
    ;
    Jemuovic, Zvezdana (57195299822)
    ;
    Milojevic, Toplica (57184201100)
    ;
    Milicevic, Mihailo (57219130278)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Stojanoska, Milica Medic (23389630200)
    ;
    Carić, Bojana (57226110329)
    ;
    Radic, Nevena (57193631673)
    ;
    Medenica, Sanja (33568078600)
    ;
    Gacic, Emilija Manojlovic (57195247701)
    ;
    Petakov, Milan (7003976693)
    Pituitary xanthogranulomatomas (XG) are a rare pathological entity caused by accumulation of lipid laden macrophages and reactive granuloma formation usually triggered by cystic fluid leakage or hemorrhage. Our aim was to compare clinical characteristics and presenting features of patients with secondary etiology of XG and those with no identifiable founding lesion (primary-“pure” XG) in order to gain new insights into this rare pituitary pathology. In a retrospective review of 714 patients operated for sellar masses, at tertiary center, we identified 16 (2.24%) with histologically confirmed diagnosis of pituitary XG over the period of 7 years (2015–2021). Patients were further analyzed according to XG etiology: “pure”-XG (n = 8) with no identifiable founding lesion were compared to those with histological elements of pituitary tumor or cyst – secondary XG (n = 8). We identified 16 patients (11 male), mean age 44.8 ± 22.3 years, diagnosed with pituitary XG. Secondary forms were associated with Ratke’s cleft cyst (RCC, n = 2) and pituitary adenoma (PA, n = 6). The most common presenting features in both groups were hypopituitarism (75%), headache (68.5%) and visual disturbances (37.5%). Predominance of male sex was noted (males 68.75%, females 31.25%), especially in patients with primary forms. Patients with primary pituitary XG were all males (p = 0.0256) and more frequently affected by panhypopituitarism (87.5% vs. 25%, p = 0.0406) compared to patients with secondary causes. Hyperprolactinemia was noted in pituitary tumor group with secondary etiology only (p = 0.0769). Majority of lesions were solid on magnetic resonance imaging-MRI (81.25%). Distinct clinical phenotype was observed dependent on the etiology of XG. © The Japan Endocrine Society.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Silent brain ischemia within the TAXINOMISIS framework: association with clinical and advanced ultrasound metrics
    (2024)
    Kigka, Vassiliki (57196149573)
    ;
    Carrozzi, Alessandro (55938318200)
    ;
    Gramegna, Laura Ludovica (55501926000)
    ;
    Siogkas, Panagiotis K. (36976596100)
    ;
    Potsika, Vassiliki (55826618900)
    ;
    Tsakanikas, Vassilis (36718299600)
    ;
    Kallmayer, Michael (41861588900)
    ;
    Obach, Victor (6701732295)
    ;
    Riambau, Vincente (59404179600)
    ;
    Spinella, Giovanni (24825428100)
    ;
    Pratesi, Giovanni (57194726932)
    ;
    Cirillo, Luigi (35787008700)
    ;
    Manners, David Neil (7004151863)
    ;
    Pini, Rodolfo (57195394214)
    ;
    Faggioli, Gianluca (7004387660)
    ;
    de Borst, Gert J. (24464360800)
    ;
    Galyfos, George (55658700300)
    ;
    Sigala, Frangiska (55393308900)
    ;
    Mutavdzic, Perica (56321930600)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Koncar, Igor (19337386500)
    ;
    Fotiadis, Dimitros I. (55938920100)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Silent brain ischemia within the TAXINOMISIS framework: association with clinical and advanced ultrasound metrics
    (2024)
    Kigka, Vassiliki (57196149573)
    ;
    Carrozzi, Alessandro (55938318200)
    ;
    Gramegna, Laura Ludovica (55501926000)
    ;
    Siogkas, Panagiotis K. (36976596100)
    ;
    Potsika, Vassiliki (55826618900)
    ;
    Tsakanikas, Vassilis (36718299600)
    ;
    Kallmayer, Michael (41861588900)
    ;
    Obach, Victor (6701732295)
    ;
    Riambau, Vincente (59404179600)
    ;
    Spinella, Giovanni (24825428100)
    ;
    Pratesi, Giovanni (57194726932)
    ;
    Cirillo, Luigi (35787008700)
    ;
    Manners, David Neil (7004151863)
    ;
    Pini, Rodolfo (57195394214)
    ;
    Faggioli, Gianluca (7004387660)
    ;
    de Borst, Gert J. (24464360800)
    ;
    Galyfos, George (55658700300)
    ;
    Sigala, Frangiska (55393308900)
    ;
    Mutavdzic, Perica (56321930600)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Koncar, Igor (19337386500)
    ;
    Fotiadis, Dimitros I. (55938920100)
    [No abstract available]
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The sellar region as presenting theater for hematologic malignancies—A 17-year single-center experience
    (2022)
    Pekic, Sandra (6602553641)
    ;
    Stojanovic, Marko (58191563300)
    ;
    Gacic, Emilija Manojlovic (57195247701)
    ;
    Antic, Darko (23979576100)
    ;
    Milojevic, Toplica (57184201100)
    ;
    Milicevic, Mihajlo (57219130278)
    ;
    Stanimirovic, Aleksandar (57215793610)
    ;
    Doknic, Mirjana (6603478362)
    ;
    Miljic, Dragana (6505968542)
    ;
    Banjalic, Sandra (56315638800)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Jemuovic, Zvezdana (57195299822)
    ;
    Djurovic, Marina Nikolic (6603668923)
    ;
    Grujicic, Danica (7004438060)
    ;
    Popovic, Vera (35451450900)
    ;
    Petakov, Мilan (57913657000)
    Hematological neoplastic mass lesions of the sellar region are rare. We identified five cases of hematological malignancy with first presentation in the sellar region from our departmental database of 1,405 patients (0.36%) with sellar lesions diagnosed over the 17-year period (2005–2021). All patients were females (mean age 55.2 ± 3.4 years). One patient had multiple myeloma (MM), one patient had acute myeloid leukemia (AML), while three other patients had lymphoma (intravascular lymphoma (IVL, n = 1) or non-Hodgkin’s lymphoma (NHL, n = 2). Most patients presented with ophthalmoplegia, and one patient with diabetes insipidus (DI), with short duration of symptoms (median 30 days). All patients had an elevated erythrocyte sedimentation rate and altered blood count, while patients with lymphoma had elevated lactate dehydrogenase (LDH). Sellar mass was demonstrated in three patients while the patient with IVL had an empty sella and in the AML patient posterior lobe T1W hyperintensity was lost. Two patients (IVL and NHL) presented with multiple anterior pituitary deficiencies and one patient (AML) had DI. All patients were treated with chemotherapy. Two patients responded well to treatment (one had reversed hypopituitarism), while three patients died. Differential diagnosis of sellar-parasellar pathology should include suspicion of hematological malignancy, particularly in patients with short duration of nonspecific symptoms, neurological signs (ophthalmoplegia), blood count alterations and LDH elevation, pituitary dysfunction and imaging features atypical for pituitary adenoma. Early diagnosis is crucial for timely initiation of hematological treatment aimed at inducing disease remission and partial or full recovery of pituitary function. © The Japan Endocrine Society.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The sellar region as presenting theater for hematologic malignancies—A 17-year single-center experience
    (2022)
    Pekic, Sandra (6602553641)
    ;
    Stojanovic, Marko (58191563300)
    ;
    Gacic, Emilija Manojlovic (57195247701)
    ;
    Antic, Darko (23979576100)
    ;
    Milojevic, Toplica (57184201100)
    ;
    Milicevic, Mihajlo (57219130278)
    ;
    Stanimirovic, Aleksandar (57215793610)
    ;
    Doknic, Mirjana (6603478362)
    ;
    Miljic, Dragana (6505968542)
    ;
    Banjalic, Sandra (56315638800)
    ;
    Jovanovic, Marija (57194767566)
    ;
    Jemuovic, Zvezdana (57195299822)
    ;
    Djurovic, Marina Nikolic (6603668923)
    ;
    Grujicic, Danica (7004438060)
    ;
    Popovic, Vera (35451450900)
    ;
    Petakov, Мilan (57913657000)
    Hematological neoplastic mass lesions of the sellar region are rare. We identified five cases of hematological malignancy with first presentation in the sellar region from our departmental database of 1,405 patients (0.36%) with sellar lesions diagnosed over the 17-year period (2005–2021). All patients were females (mean age 55.2 ± 3.4 years). One patient had multiple myeloma (MM), one patient had acute myeloid leukemia (AML), while three other patients had lymphoma (intravascular lymphoma (IVL, n = 1) or non-Hodgkin’s lymphoma (NHL, n = 2). Most patients presented with ophthalmoplegia, and one patient with diabetes insipidus (DI), with short duration of symptoms (median 30 days). All patients had an elevated erythrocyte sedimentation rate and altered blood count, while patients with lymphoma had elevated lactate dehydrogenase (LDH). Sellar mass was demonstrated in three patients while the patient with IVL had an empty sella and in the AML patient posterior lobe T1W hyperintensity was lost. Two patients (IVL and NHL) presented with multiple anterior pituitary deficiencies and one patient (AML) had DI. All patients were treated with chemotherapy. Two patients responded well to treatment (one had reversed hypopituitarism), while three patients died. Differential diagnosis of sellar-parasellar pathology should include suspicion of hematological malignancy, particularly in patients with short duration of nonspecific symptoms, neurological signs (ophthalmoplegia), blood count alterations and LDH elevation, pituitary dysfunction and imaging features atypical for pituitary adenoma. Early diagnosis is crucial for timely initiation of hematological treatment aimed at inducing disease remission and partial or full recovery of pituitary function. © The Japan Endocrine Society.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback